Peregrine Pharmaceuticals

Peregrine slashes R&D in a reorg that claims 60 jobs; Zai Labs in hunt for $150M IPO – report
Endpoints
Sat, 08/12/17 - 11:53 am
Peregrine Pharmaceuticals
reorganization
Zai Labs
IPOs
Peregrine reports 2Q loss
Yahoo/AP
Tue, 12/13/16 - 10:15 am
Peregrine Pharmaceuticals
earnings
Peregrine reports 3Q loss
Yahoo/AP
Wed, 03/9/16 - 09:19 am
Peregrine Pharmaceuticals
earnings
Peregrine reports 2nd-quarter loss but tops expectations
Yahoo/AP
Thu, 12/10/15 - 06:29 pm
Peregrine Pharmaceuticals
earnings
It's the Little Things That Matter for Peregrine Pharmaceuticals
Motley Fool
Fri, 12/4/15 - 08:11 pm
Peregrine Pharmaceuticals
bavituximab
cancer immunotherapy
Three Small Companies With Big Name Partnerships In Immuno-Oncology
Yahoo
Tue, 12/1/15 - 02:41 pm
immuno-oncology
Peregrine Pharmaceuticals
AstraZenca
MabVax Therapeutics
Juno Therapeutics
CTI BioPharma
Peregrine posts loss of $13.7 million in 1st quarter
Yahoo/AP
Wed, 09/9/15 - 09:58 pm
Peregrine Pharmaceuticals
earnings
AstraZeneca Oncology Partnerships To Help Recover Sales
Bidness ETC
Tue, 08/25/15 - 09:43 am
AstraZeneca
oncology
Pfizer
Peregrine Pharmaceuticals
Heptares Therapeutics
Mirati Therapeutics
Juno Therapeutics
3 Keys to Success for Peregrine Pharmaceuticals
Investopedia
Sat, 03/21/15 - 10:48 am
Peregrine Pharmaceuticals
19 Lesser-Known Biotech Stocks With Robust Drug Pipelines
Yahoo/Benzinga
Wed, 12/31/14 - 10:37 am
biotech
Threshold Pharmaceuticals
Acceleron
Spectrum Pharmaceuticals
Ultragenyx
Argos Therapeutics
OncoMed
Peregrine Pharmaceuticals
Incyte
Calithera
Array Biopharma
Theravance
Puma Biotechnology
CTI BioPharma
Orexigen
Enanta Pharmaceuticals
Sucampo
Exelixis
Cubist Pharmaceuticals
United Therapeutics
Peregrine Pharmaceuticals' Q1 Loss Wider than Expected
Yahoo/Zacks.com
Wed, 09/10/14 - 08:55 am
Peregrine Pharmaceuticals
earnings
Could a Vaccine-Based Cancer Cure Be Around the Corner?
Motley Fool
Sun, 05/18/14 - 10:20 am
Merck
Galena Biopharma
Peregrine Pharmaceuticals
Just How Important Is Bavituximab to Peregrine Pharmaceuticals?
Motley Fool
Tue, 03/11/14 - 02:58 pm
bavituximab
Peregrine Pharmaceuticals
non-small cell lung cancer
22 Biotech Stock Predictions for 2014
TheStreet.com
Mon, 01/6/14 - 09:47 am
biotech
Vertex Pharmaceuticals
Orexigen
Retrophin
Valeant Pharmaceuticals
Questcor
Biomarin
Merck
NeoStem
Amgen
Gilead Sciences
Vanda
Keryx
Peregrine Pharmaceuticals
CelSci
Regeneron
Cempra
Dendreon
Clovis Oncology
Halozyme
NPS Pharmaceuticals
The Race For A Cure For Cancer
Seeking Alpha
Thu, 11/21/13 - 12:09 pm
cancer
Merck
Bristol-Myers Squibb
Roche
Peregrine Pharmaceuticals
Peregrine presents data on bavituximab combined with anti-CTLA-4 antibodies
The Fly on the Wall
Fri, 11/8/13 - 10:05 am
bavituximab
Peregrine Pharmaceuticals
CTLA-4 monoclonal antibody
Drug Development Risk #364: Poorly Run Clinical Trials
Motley Fool
Tue, 09/24/13 - 10:10 am
R&D
clinical trials
Merck
Vertex Pharmaceuticals
Peregrine Pharmaceuticals
JNJ
Bridion
5 Experimental Drugs That Could Make a Big Difference in Treating Lung Cancer
Motley Fool
Sun, 09/22/13 - 11:23 am
LDK378
Novartis
bavituximab
Peregrine Pharmaceuticals
nivolumab
Bristol-Myers Squibb
lambrolizumab
Merck
lung cancer
CO-1686
Clovis Oncology
Is This Experimental Lung Cancer Drug Back on Track?
Motley Fool
Tue, 09/10/13 - 11:55 am
lung cancer
Peregrine Pharmaceuticals
bavituximab
Peregrine's 4Q Loss In Line
Yahoo/Zacks
Mon, 07/15/13 - 01:40 pm
earnings
Peregrine Pharmaceuticals

Pages